ArticlePLoS neglected tropical diseases2014
Global programme to eliminate lymphatic filariasis: the processes underlying programme success.
Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 75 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Community Studies to Monitor the Impact of Triple Drug Therapy Relative to Double Drug Therapy on Lymphatic Filariasis Infection Indicators
A Clinical Trial to Assess the Safety and Efficacy of Moxidectin Combination Treatments vs. Ivermectin Combination Treatments for Bancroftian Filariasis
Who cites it
75 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Meta-analysis of the prevalence ofFrontiers in cellular and infection microbiology · 2025Pooled it
- Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.PLoS neglected tropical diseases · 2019Pooled it
- Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required.Pathogens and global health · 2019Pooled it
- Evaluating the effectiveness of mass drug administration on lymphatic filariasis transmission and assessment of post-mass drug administration surveillance in Nigeria's Federal Capital Territory.Infectious diseases of poverty · 2025Article
- Implementation of basic package of care improved socio-economic conditions of lymphedema patients in rural Mali after two years follow-up.PLOS global public health · 2025Article
- Exploring barriers to accessing treatment for Lymphatic Filariasis through a socio-ecological lens in Buvuma and Napak districts, Uganda.PLoS neglected tropical diseases · 2025Article
- Lessons from integrating mental health as part of lymphatic filariasis morbidity management and disability prevention services in Jigawa State, Nigeria.International health · 2024Article
- The national distribution of lymphatic filariasis cases in Malawi using patient mapping and geostatistical modelling.PLoS neglected tropical diseases · 2024Article
- Identification and prioritisation of potential vaccine candidates using subtractive proteomics and designing of a multi-epitope vaccine against Wuchereria bancrofti.Scientific reports · 2024Article
- Designing of a chimeric multiepitope vaccine against bancroftian lymphatic filariasis through immunoinformatics approaches.PloS one · 2024Article
- Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings.Journal of cellular and molecular medicine · 2023Review
- Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.PLoS neglected tropical diseases · 2023Article
- Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.PLoS neglected tropical diseases · 2023Article
- Evaluating the availability and quality of services for lymphatic filariasis morbidity in Ghana.PLoS neglected tropical diseases · 2023Article
- Molecular detection ofCurrent research in parasitology & vector-borne diseases · 2023Article
- Crude protein fraction with high thioredoxin reductase (TrxR) enzyme activity from filarial parasite Setaria cervi counters lipopolysaccharide (LPS)-induced inflammation in macrophages.Parasitology research · 2022Article
- Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.Pharmaceuticals (Basel, Switzerland) · 2021Article
- Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.PLoS neglected tropical diseases · 2021Review
- Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.PLoS neglected tropical diseases · 2021Article
- High concentrations of membrane-fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti.Parasites & vectors · 2021Article
15 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.